Explore the Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Clinical Next-Generation Sequencing (NGS) Data Analysis Market

Key Insight

Clinical next-generation sequencing (NGS) data analysis sales will expand through 2036, with NGS data analysis tools holding 29.6% of the solution and services segment in 2026. The market was valued at USD 3.20 billion in 2025 and is expected to be worth USD 18.51 billion by 2036, creating an incremental opportunity of USD 14.79 billion.

May 27, 2026

Anurag Sharma

530 Pages

Cite this Report

Clinical Next-Generation Sequencing (NGS) Data Analysis Market

https://www.futuremarketinsights.com/reports/clinical-ngs-data-analysis-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Agilent Technologies
BGI Genomics Co. Ltd
Bio-Rad Laboratories
DNAnexus
F. Hoffmann-La Roche Ag
Fabric Genomics
Illumina
Oxford Nanopore Technologies
Pacific Biosciences Inc
PerkinElmer
Qiagen
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Clinical Next-Generation Sequencing (NGS) Data Analysis Market

Key Players

Similar Industry Reports